Cargando…
Rupatadine Protects against Pulmonary Fibrosis by Attenuating PAF-Mediated Senescence in Rodents
A similar immune response is implicated in the pathogenesis of pulmonary fibrosis and allergic disorders. We investigated the potential therapeutic efficacy and mechanism of rupatadine, a dual antagonist of histamine and platelet-activation factor (PAF), in bleomycin- (BLM-) and silica-induced pulmo...
Autores principales: | Lv, Xiao-xi, Wang, Xiao-xing, Li, Ke, Wang, Zi-yan, Li, Zhe, Lv, Qi, Fu, Xiao-ming, Hu, Zhuo-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711902/ https://www.ncbi.nlm.nih.gov/pubmed/23869224 http://dx.doi.org/10.1371/journal.pone.0068631 |
Ejemplares similares
-
Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects
por: Shamizadeh, Soja, et al.
Publicado: (2014) -
Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013) -
Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription
por: Zheng, Jing-Jie, et al.
Publicado: (2020) -
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
por: Zhang, Tingwei, et al.
Publicado: (2022) -
N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence
por: Huang, Pu, et al.
Publicado: (2022)